In situ click chemistry: Enzyme inhibitors made to their own specifications

Journal of the American Chemical Society

Volumn 126, Issue 40, 2004, Pages 12809-12818

  Manetsch, Roman ^a   Krasiński, Antoni ^a   Radić, Zoran ^b   Raushel, Jessica ^a   Taylor, Palmer ^b   Sharpless, K Barry ^a   Kolb, Hartmuth C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLENE; BIOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

BIOLOGICAL TARGETS; CLICK CHEMISTRY; PHARMACORES;

ENZYME INHIBITION;

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR;

ARTICLE; COMBINATORIAL CHEMISTRY; COMPUTER PROGRAM; HIGH THROUGHPUT SCREENING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHARMACOPHORE; REACTION OPTIMIZATION; SYNTHESIS;

EID: 5644276317     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja046382g     Document Type: Article

References (52)

1. Nicolaou, K. C.; Hanko, R.; Hartwig, W. In Handbook of Combinatorial Chemistry; Nicolaou, K. C., Hanko, R., Hartwig, W., Eds.; Wiley-VCH: Weinheim, Germany, 2002; Vol. 1, pp 3-9.
2. Kolb, H. C.; Sharpless, K. B. Drug Discovery Today 2003, 8, 1128-1137.
3. Terrett, N. Combinatorial Chemistry; Oxford University Press: Oxford, U.K., 1998.
4. Nicolaou, K. C.; Hanko, R.; Hartwig, W. , 2002; Vol. 1.
5. Nicolaou. K. C.; Hanko, R.; Hartwig, W. Handbook of Combinatorial Chemistry; Wiley-VCH: Weinheim, Germany, 2002; Vol. 2.
6. Kassel, D. B.; Myers, P. L. Pharm. News 2002, 9, 171-177.
7. Geysen, H. M.; Schoenen, F.; Wagner, D.; Wagner, R. Nat. Rev. Drug Discovery 2003, 2, 222-230.
8. Fixing the drugs pipeline. The Economist, March 11, 2004; available online at http://www.economist.com/printedition/displayStory.cfm?Story_ID= 2477075.
9. Kubinyi, H. Nat. Rev. Drug Discovery 2003, 2, 665-668.
10. Rideout, D. Science 1986, 233, 561-563.
11. Rideout, D.; Calogeropoulou, T.; Jaworski, J.; McCarthy, M. Biopolymers 1990, 29, 247-262.
12. Huc, I.; Lehn, J.-M. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 2106-2110.
13. Ramstrom, O.; Lehn, J.-M. ChemBioChem 2000, 1, 41-48.
14. Lehn, J.-M.; Eliseev, A. V. Science 2001, 291, 2331-2332.
15. Bunyapaiboonsri, T.; Ramstrom, O.; Lohmann, S.; Lehn, J.-M.; Peng, L.; Goeldner, M. ChemBioChem 2001, 2, 438-444.
16. Eliseev, A. V. Pharm. News 2002, 9, 207-215.
17. Ramstrom, O.; Lehn, J.-M. Nat. Rev. Drug Discovery 2002, 1, 26-36.
18. Otto, S. Curr. Opin. Drug Discovery Dev. 2003, 6, 509-520.
19. Erlanson, D. A.; Braisted, A. C.; Raphael, D. R.; Randal, M.; Stroud, R. M.; Gordon, E. M.; Wells, J. A. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 9367-9372.
20. Erlanson, D. A.; Lam, J. W.; Wiesmann, C.; Luong, T. N.; Simmons, R. L.; DeLano, W. L.; Choong, I. C.; Burden, M. T.; Flanagan, W. M.; Lee, D.; Gordon, E. M.; O'Brien, T. Nat. Biotechnol. 2003, 21, 308-314.
21. Ramström, O.; Lohmann, S.; Bunyapaiboonsri, T.; Lehn, J.-M. Chem.-Eur. J. 2004, 10, 1711-1715.
22. Maly, D. J.; Choong. I. C.; Ellman, J. A. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 2419-2424.
23. Kehoe, J. W.; Maly, D. J.; Verdugo, D. E.; Armstrong, J. I.; Cook, B. N.; Ouyang, Y.-B.; Moore, K. L.; Ellman, J. A.; Bertozzi, C. R. Bioorg. Med. Chem. Lett. 2002, 12, 329-332.
24. Lewis, W. G.; Green, L. G.; Grynszpan, F.; Radic, Z.; Carlier, P. R.; Taylor, P.; Finn, M. G.; Sharpless, K. B. Angew. Chem., Int. Ed. 2002, 41, 1053-1057.
25. Bourne, Y.; Kolb, H. C.; Radiç, Z.; Sharpless, K. B.; Taylor. P.; Marchot, P. Proc. Natl. Acad. Sci., U.S.A. 2004, 101, 1449-1454.
26. Inglese, J.; Benkovic, S. J. Tetrahedron 1991, 47, 2351-2364.
27. Boger, D. L.; Haynes, N.-E.; Kitos, P. A.; Warren, M. S.; Ramcharan, J.; Marolewski, A. E.; Benkovic, S. J. Bioorgan. Med. Chem. 1997, 5, 1817-1830.
28. Greasley, S. E.; Marsilje, T. H.; Cai, H.; Baker, S.; Benkovic, S. J.; Boger, D. L.; Wilson, I. A. Biochemistry 2001, 40, 13538-13547.
29. Nguyen, R.; Huc, I. Angew. Chem., Int. Ed. 2001, 40, 1774-1776.
30. Nicolaou, K. C.; Hughes, R.; Cho, S. Y.; Winssinger, N.; Smethurst, C.; Labischinski, H.; Endermann, R. Angew. Chem., Int. Ed. 2000, 39, 3823-3828.
31. Nicolaou, K. C.; Hughes, R.; Cho, S. Y.; Winssinger, N.; Labischinski, H.; Endermann, R. Chem.-Eur. J. 2001, 7, 3824-3843.
32. Huisgen, R. In 1,3-Dipolar Cycloaddition Chemistry; Padwa, A., Ed.; Wiley: New York, 1984; Vol. 1, pp 1-176.
33. Mock, W. L.; Irra, T. A.; Wepsiec, J. P.; Manimaran, T. L. J. Org. Chem. 1983, 48, 3619-3620.
34. Mock, W. L.; Irra, T. A.; Wepsiec, J. P.; Adhya, M. J. Org. Chem. 1989, 54, 5302-5308.
35. Mock, W. L. Top. Curr. Chem. 1995, 175, 1-24.
36. Taylor, P.; Radic, Z. Annu. Rev. Pharmacol. Toxicol. 1994, 34, 281-320.
37. Argyl-Robertson, D. Edinburgh Med. J. 1863, 8, 815-820.
38. Dale, H. H. J. Pharmacol. Exp. Ther. 1914, 6, 147-190.
39. Sussman, J. L.; Harel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. Science 1991, 253, 872-879.
40. Harel, M.; Schalk, I.; Ehret-Sabatier, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P. H.; Silman, I.; Sussman, J. L. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 9031-9035.
41. Wei, J.; Buriak, J. M.; Siuzdak, G. Nature 1999, 399, 243-246.
42. -1 24). Apart from the expected entropic stabilization, the transition state may also experience stabilization through hydrogen bonding and stacking interactions with the protein.25
43. The in situ screening experiments were generally performed with the following concentrations: 1 μM for the enzyme, 4.6 μM for tacrine components, and 24 μM for phenylphenanthridinium components. Because of the sensitive nature of the analysis method, the building block concentrations can be reduced to as low as 1 μM for tacrine reagents and 6 μM for phenylphenanthridinium reagents, without a significant loss of intensity of the product peak. However, lowering the phenylphenanthridinium component concentration to 1 μM dramatically decreased the reaction rate and makes the intensity of the product signal prohibitively small.
44. The computation was performed at the Swiss Institute of Bioinformatics (SIB) using the BLAST network service. The SIB BLAST network service uses a server developed at SIB and the National Center for Biotechnology Information (NCBI) BLAST 2 software.
45. Altschul, S. F.; Madden, T. L.; Schäffer, A. A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D. J. Nucleic Acids Res. 1997, 25, 3389-3402.
46. Rostovtsev, V. V.; Green. L. G.; Fokin, V. V.; Sharpless, K. B. Angew. Chem., Int. Ed. 2002, 41, 2596-2599.
47. Tornøe, C. W.; Christensen, C.; Meldal, M. J. Org. Chem. 2002, 67, 3057-3064.
48. All samples were analyzed by LC/MS-SIM with electrospray detection on a Cyclobond 1 2000 DMP column (4.6 × 100 mm, preceded by a Phenomenex C18 ODS guard column) using isocratic elution conditions.
49. Radic, Z.; Pickering, N. A.; Vellom, D. C.; Camp, S.; Taylor, P. Biochemistry 1993, 32, 12074-12084.
50. Marchot, P.; Ravelli, R. B. G.; Raves, M. L.; Bourne, Y.; Vellom, D. C.; Kanter, J.; Camp, S.; Sussman, J. L.; Taylor, P. Protein Sci. 1996, 5, 672-679.
51. Radic, Z.; Taylor, P. J. Biol. Chem. 2001, 276, 4622-4633.
52. Ellman, G. L.; Courtney, K. D.; Valentino Andres, J.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95.